Eisai
4523.T
#2142
Rank
HK$70.54 B
Marketcap
HK$249.96
Share price
3.73%
Change (1 day)
12.58%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : HK$25.91 Billion

According to Eisai's latest financial reports the company's total liabilities are HK$25.91 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eisai - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-03-31HK$25.97 B-13.5%
2022-03-31HK$30.03 B17.68%
2021-03-31HK$25.51 B-1.07%
2020-03-31HK$25.79 B-13.06%
2019-03-31HK$29.66 B-7.6%
2018-03-31HK$32.10 B7.86%
2017-03-31HK$29.76 B8.59%
2016-03-31HK$27.41 B-6.06%
2015-03-31HK$29.18 B-12.89%
2014-03-31HK$33.50 B-21.13%
2013-03-31HK$42.48 B-21.99%
2012-03-31HK$54.45 B-8.45%
2011-03-31HK$59.48 B5.32%
2010-03-31HK$56.48 B0.87%
2009-03-31HK$55.99 B7.22%
2008-03-31HK$52.22 B243.11%
2007-03-31HK$15.22 B0.89%
2006-03-31HK$15.08 B2.09%
2005-03-31HK$14.77 B0.76%
2004-03-31HK$14.66 B9.06%
2003-03-31HK$13.44 B23.33%
2002-03-31HK$10.90 B-13.01%
2001-03-31HK$12.53 B